{"id":3143,"date":"2017-03-24T06:43:33","date_gmt":"2017-03-24T06:43:33","guid":{"rendered":"https:\/\/www.enhancedsolutions.com\/dravaliani\/hot-news-juvederm-vollure-xc-will-available-april-2017\/"},"modified":"2017-03-24T06:43:33","modified_gmt":"2017-03-24T06:43:33","slug":"hot-news-juvederm-vollure-xc-will-available-april-2017","status":"publish","type":"post","link":"https:\/\/www.enhancedsolutions.com\/dravaliani\/hot-news-juvederm-vollure-xc-will-available-april-2017\/","title":{"rendered":"HOT NEWS! JUV\u00c9DERM VOLLURE\u2122 XC will be available April 2017"},"content":{"rendered":"<p><em>Written by Anna Avaliani MD<\/em><\/p>\n<p><strong>Say Good bye to smile lines for up to 18 months!<\/strong><\/p>\n<p>Allergan approved a new dermal filler and added another family member to their line of dermal fillers made with VYCROSS\u00ae technology. The new filler is called JUV\u00c9DERM VOLLURE\u2122 XC and is FDA approved for correction of moderate to severe facial wrinkles and folds, such as nasolabial folds (smile lines), in adults over the age of 21.<\/p>\n<p>JUV\u00c9DERM VOLLURE\u2122 XC has been used in Europe since 2013 under the name JUV\u00c9DERM VOLIFT\u2122 XC.<\/p>\n<p><strong>What is JUV\u00c9DERM VOLLURE\u2122 XC?<\/strong><br \/>\nJUV\u00c9DERM VOLLURE\u2122 XC is an injectable gel is for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds in adults over the age of 21.<\/p>\n<p><img class=\\\"alignnone size-full wp-image-3144\\\" src=\\\"http:\/\/www.dravaliani.com\/wp-content\/uploads\/2017\/03\/vollure2.jpg\\\"><\/p>\n<p><strong>What is unique about JUV\u00c9DERM VOLLURE\u2122 XC?<\/strong><br \/>\nIt is made with the VYCROSS\u00ae technology with allows the product to be longer lasting. In clinical trials, patient had high satisfaction rates of 82% at 6 months after initial injection and 59% were still satisfied with their appearance at 18 months<\/p>\n<p><strong>How long does JUV\u00c9DERM VOLLURE\u2122 XC? Last?<\/strong><br \/>\nUp to 18 months<\/p>\n<p><strong>When is it available to physicians?<\/strong><br \/>\nDr.Avaliani will be one of the first doctors to offer this product to her patients in 2017!<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Written by Anna Avaliani MD Say Good bye to smile lines for up to 18 months! Allergan approved a new dermal filler and added another family member to their line of dermal fillers made with VYCROSS\u00ae technology. The new filler is called JUV\u00c9DERM VOLLURE\u2122 XC and is FDA approved for correction of moderate to severe [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3145,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1],"tags":[],"class_list":["post-3143","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"spectra_custom_meta":{"_edit_last":["1"],"_thumbnail_id":["3145"],"_yoast_wpseo_content_score":["30"],"_yoast_wpseo_primary_category":["1"],"_uag_page_assets":["a:9:{s:3:\"css\";s:0:\"\";s:2:\"js\";s:0:\"\";s:18:\"current_block_list\";a:0:{}s:8:\"uag_flag\";b:0;s:11:\"uag_version\";s:10:\"1775214754\";s:6:\"gfonts\";a:0:{}s:10:\"gfonts_url\";s:0:\"\";s:12:\"gfonts_files\";a:0:{}s:14:\"uag_faq_layout\";b:0;}"]},"uagb_featured_image_src":{"full":["https:\/\/www.enhancedsolutions.com\/dravaliani\/wp-content\/uploads\/2017\/03\/vollure.jpg",460,200,false],"thumbnail":["https:\/\/www.enhancedsolutions.com\/dravaliani\/wp-content\/uploads\/2017\/03\/vollure-150x150.jpg",150,150,true],"medium":["https:\/\/www.enhancedsolutions.com\/dravaliani\/wp-content\/uploads\/2017\/03\/vollure-300x130.jpg",300,130,true],"medium_large":["https:\/\/www.enhancedsolutions.com\/dravaliani\/wp-content\/uploads\/2017\/03\/vollure.jpg",460,200,false],"large":["https:\/\/www.enhancedsolutions.com\/dravaliani\/wp-content\/uploads\/2017\/03\/vollure.jpg",460,200,false],"1536x1536":["https:\/\/www.enhancedsolutions.com\/dravaliani\/wp-content\/uploads\/2017\/03\/vollure.jpg",460,200,false],"2048x2048":["https:\/\/www.enhancedsolutions.com\/dravaliani\/wp-content\/uploads\/2017\/03\/vollure.jpg",460,200,false],"gform-image-choice-sm":["https:\/\/www.enhancedsolutions.com\/dravaliani\/wp-content\/uploads\/2017\/03\/vollure.jpg",300,130,false],"gform-image-choice-md":["https:\/\/www.enhancedsolutions.com\/dravaliani\/wp-content\/uploads\/2017\/03\/vollure.jpg",400,174,false],"gform-image-choice-lg":["https:\/\/www.enhancedsolutions.com\/dravaliani\/wp-content\/uploads\/2017\/03\/vollure.jpg",460,200,false]},"uagb_author_info":{"display_name":"admin","author_link":"https:\/\/www.enhancedsolutions.com\/dravaliani\/author\/admin\/"},"uagb_comment_info":0,"uagb_excerpt":"Written by Anna Avaliani MD Say Good bye to smile lines for up to 18 months! Allergan approved a new dermal filler and added another family member to their line of dermal fillers made with VYCROSS\u00ae technology. The new filler is called JUV\u00c9DERM VOLLURE\u2122 XC and is FDA approved for correction of moderate to severe&hellip;","_links":{"self":[{"href":"https:\/\/www.enhancedsolutions.com\/dravaliani\/wp-json\/wp\/v2\/posts\/3143","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.enhancedsolutions.com\/dravaliani\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.enhancedsolutions.com\/dravaliani\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.enhancedsolutions.com\/dravaliani\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.enhancedsolutions.com\/dravaliani\/wp-json\/wp\/v2\/comments?post=3143"}],"version-history":[{"count":0,"href":"https:\/\/www.enhancedsolutions.com\/dravaliani\/wp-json\/wp\/v2\/posts\/3143\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.enhancedsolutions.com\/dravaliani\/wp-json\/wp\/v2\/media\/3145"}],"wp:attachment":[{"href":"https:\/\/www.enhancedsolutions.com\/dravaliani\/wp-json\/wp\/v2\/media?parent=3143"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.enhancedsolutions.com\/dravaliani\/wp-json\/wp\/v2\/categories?post=3143"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.enhancedsolutions.com\/dravaliani\/wp-json\/wp\/v2\/tags?post=3143"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}